U.S. Markets open in 6 hrs 17 mins

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Achillion Pharmaceuticals, Inc. (NASDAQ GS: ACHN)

BALA CYNWYD, PA / ACCESSWIRE / October 16, 2019 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Achillion Pharmaceuticals, Inc. ("Achillion" or "the Company") (ACHN) for possible breaches of fiduciary duty and other violations of federal and state law in connection with proposed acquisition of the Company by Alexion Pharmaceuticals, Inc. ("Alexion") (ALXN). Under the terms of the agreement, Achillion shareholders will receive only $6.50 plus one contractual contingent value right ("CVR") for each share of Achillion common stock owned.

The investigation concerns whether the Achillion Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Alexion is underpaying for the Company. The transaction may undervalue the Company and would result in a substantial loss for many Achillion shareholders. For example, the stock has traded at over $14.50 a share in the last five years.

If you own shares of Achillion stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://www.brodskysmith.com/cases/achillion-pharmaceuticals-inc-nasdaq-gs-achn/, or calling toll free 877-534-2590.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC



View source version on accesswire.com:
https://www.accesswire.com/563254/SHAREHOLDER-NOTICE-Brodsky-Smith-LLC-Announces-an-Investigation-of-Achillion-Pharmaceuticals-Inc-NASDAQ-GS-ACHN